The role of 11β-hydroxysteroid dehydrogenase 1 in adipogenesis in thyroid-associated ophthalmopathy

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 1, 2010, Pages 398-406

  Tomlinson, Jeremy W ^a   Durrani, Omar M ^a   Bujalska, Iwona J ^a   Gathercole, Laura L ^a   Tomlins, Paul J ^a   Reuser, Tristan T Q ^a   Rose, Geoffrey E ^b   Curnow, S John ^a   Stewart, Paul M ^a   Walker, Elizabeth A ^a   Rauz, Saaeha ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; FATTY ACID BINDING PROTEIN 4; GLUCOCORTICOID RECEPTOR ALPHA; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLYCEROL 6 PHOSPHATE DEHYDROGENASE; HYDROCORTISONE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; OXIDOREDUCTASE; TRANSFORMING GROWTH FACTOR BETA2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AUTACOID; GLUCOCORTICOID;

ADIPOCYTE; ADIPOGENESIS; ADULT; AGED; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; COLORIMETRY; CONTROLLED STUDY; ENDOCRINE OPHTHALMOPATHY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; ORBIT; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL; DRUG EFFECT; ENZYMOLOGY; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ADIPOCYTES; ADIPOGENESIS; ADULT; AGED; AGED, 80 AND OVER; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; GENE EXPRESSION; GLUCOCORTICOIDS; GRAVES OPHTHALMOPATHY; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; ORBIT; STROMAL CELLS;

EID: 75149193371     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-0873     Document Type: Article

References (45)

1. Ludgate M, Baker G 2002 Unlocking the immunological mechanisms of orbital inflammation in thyroid eye disease. Clin Exp Immunol 127:193-198
2. Heufelder AE 2000 Pathogenesis of ophthalmopathy in autoimmune thyroid eye disease. Rev Endocr Metab Disord 1:87-95
3. Kumar S, Coenen MJ, Scherer PE, Bahn RS 2004 Evidence of enhanced adipogenesis in the orbits of patients with Graves disease. J Clin Endocrinol Metab 89:930-935
4. Crisp M, Starkey KJ, Lane C, Ham J, Ludgate M 2000 Adipogenesis in thyroid eye disease. Invest Ophthalmol Vis Sci 41:3249-3255
5. Valyasevi RW, Jyonoucgi SC, Dutton CM, Munsakul N, Bahn RS 2001 Effect of tumour necrosis factor-α, interferon-γ, and expression of thyrotropin receptor in human orbital preadipocyte fibroblasts. J Clin Endocrinol Metab 86:903-908
6. Lehmann GM, Garcia-Bates TM, Smith TJ, Feldon SE, Phipps RP 2008 Regulation of lymphocyte function by PPARγ: relevance to thyroid eye disease-related inflammation. PPAR Res 2008:895901
7. Tomlinson JW, Walker EA, Bujalska IJ, Draper N, Lavery GG, Cooper MS, Hewison M, Stewart PM 2004 11β-Hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev 25:831-866
8. Draper N, Walker EA, Bujalska IJ, Tomlinson JW, Chalder SM, Arlt W, Lavery GG, Bedendo O, RayDW,Laing I, Malunowicz E, White PC, Hewison M, Mason PJ, Connell JM, Shackleton CH, Stewart PM 2003 Mutations in the genes encoding 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency. Nat Genet 34:434-439
9. Bujalska IJ, Draper N, Michialidou Z, Tomlinson JW, White PC, Chapman KE, Walker EA, Stewart PM 2005 Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11β-hydroxysteroid dehydrogenase type 1. J Mol Endocrinol 35:675-684
10. Bujalska IJ, Quinkler M, Tomlinson JW, Montague CT, Smith DM, Stewart PM 2006 Expression profiling of 11β-hydroxysteroid dehydrogenase type-1 and glucocorticoid-target genes in subcutaneous and omental human preadipocytes. J Mol Endocrinol 37:327-340
11. Masuzaki H, Yamamoto H, Kenyon CJ, Elmquist JK, Morton NM, Paterson JM, Shinyama H, Sharp MG, Fleming S, Mullins JJ, Seckl JR, Flier JS 2003 Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. J Clin Invest 112:83-90
12. Bujalska IJ, Kumar S, Stewart PM 1997 Does central obesity reflect "Cushing's disease of the omentum"? Lancet 349:1210-1213
13. Rask E, Walker BR, Söderberg S, Livingstone DEW, Eliasson M, Johnson O, Andrew R, Olsson T 2002 Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11β-hydroxysteroid dehydrogenase type 1 activity. J Clin Endocrinol Metab 87:3330-3336
14. Tomlinson JW, Finney J, Gay C, Hughes BA, Hughes SV, Stewart PM 2008 Impaired glucose tolerance and insulin resistance are associated with increased adipose 11β-hydroxysteroid dehydrogenase type 1 expression and elevated hepatic 5α-reductase activity. Diabetes 57:2652-2660
15. Alberts P, Engblom L, Edling N, Forsgren M, Klingström G, Larsson C, Rönquist-Nii Y, Ohman B, Abrahmsén L 2002 Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice. Diabetologia 45: 1528-1532
16. Alberts P, Nilsson C, Selen G, Engblom LO, Edling NH, Norling S, Klingström G, Larsson C, Forsgren M, Ashkzari M, Nilsson CE, Fiedler M, Bergqvist E, Ohman B, Björkstrand E, Abrahmsen LB 2003 Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains. Endocrinology 144:4755-4762
17. Bhat BG, Hosea N, Fanjul A, Herrera J, Chapman J, Thalacker F, Stewart PM, Rejto PA 2008 Demonstration of proof of mechanism and pharmacokinetics and pharmacodynamic relationship with 4′-cyanobiphenyl-4-sulfonic acid (6-amino-pyridin-2-yl)-amide (pf-915275), an inhibitor of 11-hydroxysteroid dehydrogenase type 1, in Cynomolgus monkeys. J Pharmacol Exp Ther 324:299-305
18. Berthiaume M, Laplante M, Festuccia W, Gélinas Y, Poulin S, Lalonde J, Joanisse DR, Thieringer R, Deshaies Y 2007 Depot-Specific Modulation of Rat Intraabdominal Adipose Tissue Lipid Metabolism by Pharmacological Inhibition of 11{beta}-Hydroxysteroid Dehydrogenase Type 1. Endocrinology 148:2391-2397
19. Wellen KE, Hotamisligil GS 2003 Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 112:1785-1788
20. Schäffler A, Schölmerich J, Salzberger B 2007 Adipose tissue as an immunological organ: Toll-like receptors, C1q/TNFs and CTRPs. Trends Immunol 28:393-399
21. Neels JG, Olefsky JM 2006 Inflamed fat: what starts the fire? J Clin Invest 116:33-35
22. Freeman L, Hewison M, Hughes SV, Evans KN, Hardie D, Means TK, Chakraverty R 2005 Expression of 11β-hydroxysteroid dehydrogenase type 1 permits regulation of glucocorticoid bioavailability by human dendritic cells. Blood 106:2042-2049
23. Schleimer RP 2004 Glucocorticoids suppress inflammation but spare innate immune responses in airway epithelium. ProcAmThorac Soc 1:222-230
24. Thieringer R, Le Grande CB, Carbin L, Cai T, Wong B, Wright SD, Hermanowski-Vosatka A 2001 11β-Hydroxysteroid dehydrogenase type 1 is induced in human monocytes upon differentiation to macrophages. J Immunol 167:30-35
25. Gilmour JS, Coutinho AE, Cailhier JF, Man TY, Clay M, Thomas G, Harris HJ, Mullins JJ, Seckl JR, Savill JS, Chapman KE 2006 Local amplification of glucocorticoids by 11β-hydroxysteroid dehydrogenase type 1 promotes macrophage phagocytosis of apoptotic leukocytes. J Immunol 176:7605-7611
26. Hardy R, Filer A, Cooper M, Parsonage G, Raza K, Hardie D, Rabbitt E, Stewart P, Buckley C, Hewison M 2006 Differential expression, function and response to inflammatory stimuli of 11β-hydroxysteroid dehydrogenase type 1 in human fibroblasts: a mechanism for tissuespecific regulation of inflammation. Arthritis Res Ther 8:R108
27. Zhang TY, Ding X, Daynes RA 2005 The expression of 11β-hydroxysteroid dehydrogenase type I by lymphocytes provides a novel means for intracrine regulation of glucocorticoid activities. J Immunol 174:879-889
28. Chapman KE, Gilmour JS, Coutinho AE, Savill JS, Seckl JR 2006 11β-Hydroxysteroid dehydrogenase type 1-a role in inflammation? Mol Cell Endocrinol 248:3-8
29. Bujalska IJ, Durrani OM, Abbott J, Onyimba CU, Khosla P, Moosavi AH, Reuser TT, Stewart PM, Tomlinson JW, Walker EA, Rauz S 2007 Characterisation of 11β-hydroxysteroid dehydrogenase 1 in human orbital adipose tissue: a comparison with subcutaneous and omental fat. J Endocrinol 192:279-288
30. Bujalska IJ, Kumar S, Hewison M, Stewart PM 1999 Differentiation of adipose stromal cells: the roles of glucocorticoids and 11β- hydroxysteroid dehydrogenase. Endocrinology 140:3188-3196
31. Cooper MS, Bujalska I, Rabbitt EA, Walker EA, Bland R, Sheppard MC, Hewison M, Stewart PM 2001 Modulation of 11β-hydroxysteroid dehydrogenase isozymes by proinflammatory cytokines in osteoblasts: an autocrine switch from glucocorticoid inactivation to activation. J Bone Miner Res 16:1037-1044
32. Wiersinga WM, Bartalena L 2002 Epidemiology and prevention of Graves disease. Thyroid 12:855-860
33. Smith TJ, Hoa N 2004 Immunoglobulins from patients with Graves' disease induce hyaluronan synthesis in their orbital fibroblasts through the self-antigen, insulin-like growth factor-I receptor. J Clin Endocrinol Metab 89:5076-5080
34. Zhang L, Baker G, Janus D, Paddon CA, Fuhrer D, Ludgate M 2006 Biological effects of thyrotropin receptor activation on human orbital preadipocytes. Invest Ophthalmol Vis Sci 47:5197-5203
35. Prabhakar BS, Bahn RS, Smith TJ 2003 Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocr Rev 24:802-835
36. Feldon SE, Park DJ, O'Loughlin CW, Nguyen VT, Landskroner-Eiger S, Chang D, Thatcher TH, Phipps RP 2005 Autologous T-lymphocytes stimulate proliferation of orbital fibroblasts derived from patients with Graves' ophthalmopathy. Invest Ophthalmol Vis Sci 46:3913-3921
37. Han R, Smith TJ 2005 Induction by IL-1β of tissue inhibitor of metalloproteinase-1 in human orbital fibroblasts: modulation of gene promoter activity by IL-4 and IFN-γ. J Immunol 174:3072-3079
38. Feldon SE, O'loughlin CW, Ray DM, Landskroner-Eiger S, Seweryniak KE, Phipps RP 2006 Activated human T lymphocytes express cyclooxygenase-2 and produce proadipogenic prostaglandins that drive human orbital fibroblast differentiation to adipocytes. Am J Pathol 169:1183-1193
39. Cawood TJ, Moriarty P, O'Farrelly C, O'Shea D 2007 Smoking and thyroid-associated ophthalmopathy: a novel explanation of the biological link. J Clin Endocrinol Metab 92:59-64
40. Bujalska IJ, Walker EA, Hewison M, Stewart PM 2002 A switch in dehydrogenase to reductase activity of 11β-hydroxysteroid dehydrogenase type 1 upon differentiation of human omental adipose stromal cells. J Clin Endocrinol Metab 87:1205-1210
41. Bujalska IJ, Gathercole LL, Tomlinson JW, Darimont C, Ermolieff J, Fanjul AN, Rejto PA, Stewart PM 2008 A novel selective 11β- hydroxysteroid dehydrogenase type 1 inhibitor prevents human adipogenesis. J Endocrinol 197:297-307
42. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS 2001Atransgenic model of visceral obesity and the metabolic syndrome. Science 294:2166-2170
43. Bujalska IJ, Hewitt KN, Hauton D, Lavery GG, Tomlinson JW, Walker EA, Stewart PM 2008 Lack of hexose-6-phosphate dehydrogenase impairs lipid mobilization from mouse adipose tissue. Endocrinology 149:2584-2591
44. Lantz M, Vondrichova T, Parikh H, Frenander C, Ridderstråle M, Asman P, Aberg M, Groop L, Hallengren B 2005 Overexpression of immediate early genes in active Graves' ophthalmopathy. J Clin Endocrinol Metab 90:4784-4791
45. Boyle B, Korányi K, Patocs A, Liko I, Szappanos A, Bertalan R, Racz K, Balazs C 2008 Polymorphisms of the glucocorticoid receptor gene in Graves ophthalmopathy. Br J Ophthalmol 92:131-134